Supervisory Pharmaceutical Scientist, DPQA IV, OPQA I, OPQ, CDER, FDA Dr
Rhee and Bae, 2015)
The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe
5-Amino-1MQ peptide therapy is an emerging treatment that targets metabolic pathways differently than conventional options
Gonzalez, A.M
In addition to its direct antioxidant activity, L-Carnitine also has been proved to increase the expression and activity of endogenous antioxidants through the activation of PPAR- 35 , nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf2) 36 , and Forkhead box O3 (FOXO3) 37 , both in vitro and in vivo